Influence of phorbol esters, and diacylglycerol kinase and lipase inhibitors on noradrenaline release and phosphoinositide hydrolysis in chromaffin cells.
作者信息
Jones J A, Owen P J, Boarder M R
机构信息
Department of Pharmacology and Therapeutics, University of Leicester.
We have investigated the modification of catecholamine efflux and inositol phosphate formation in cultured adrenal chromaffin cells by tetradecanoyl phorbol acetate (TPA) and inhibitors of diacylglycerol kinase (R 59,022) and diacylglycerol lipase (RG 80267), the two principal pathways of diacylglycerol metabolism. 2. TPA (1 nM to 1 microM) elicited a slow, calcium-dependent, sustained release of noradrenaline, which was partially blocked by the dihydropyridine calcium channel blocker (-)-202,791 and potentiated by the channel enhancer (+)-202,791. 3. R 59,022 enhanced noradrenaline efflux at 30 and 50 microM, while the lipase inhibitor RG 80267 failed to elicit release. 4. Neither R 59,022 nor RG 80267 affected bradykinin- or histamine-stimulated release, but both drugs substantially attenuated nicotine- and high K(+)-stimulated release. 5. Pretreatment for 10 min with TPA (but not the relatively inactive 4-methoxy TPA) or the non-phorbol protein kinase C stimulator mezerein potently inhibited bradykinin- and histamine-stimulated accumulation of total [3H]-inositol phosphate; inhibition of [3H]-inositol phosphate formation was also seen with 24 h TPA treatment. 6. Neither R 59,022 nor RG 80267, separately or together, affected bradykinin-stimulated [3H]-inositol phosphate formation. 7. Thus while the mechanism exists for inhibition of formation of inositol phosphates by stimulation of protein kinase C, these studies failed to show that this mechanism is activated by agonists acting on phospholipase C linked receptors.
摘要
我们研究了十四酰佛波醇乙酸酯(TPA)以及二酰基甘油激酶抑制剂(R 59,022)和二酰基甘油脂肪酶抑制剂(RG 80267)对培养的肾上腺嗜铬细胞中儿茶酚胺外流和肌醇磷酸生成的影响,这两种物质是二酰基甘油代谢的两个主要途径。2. TPA(1 nM至1 microM)引发了去甲肾上腺素的缓慢、钙依赖性、持续性释放,该释放被二氢吡啶钙通道阻滞剂(-)-202,791部分阻断,并被通道增强剂(+)-202,791增强。3. R 59,022在30 microM和50 microM时增强了去甲肾上腺素外流,而脂肪酶抑制剂RG 80267未能引发释放。4. R 59,022和RG 80267均未影响缓激肽或组胺刺激的释放,但两种药物均显著减弱了尼古丁和高钾刺激的释放。5. 用TPA(但不是相对无活性的4-甲氧基TPA)或非佛波醇蛋白激酶C刺激剂美泽瑞因预处理10分钟可有效抑制缓激肽和组胺刺激的总[3H]-肌醇磷酸积累;TPA处理24小时也可见[3H]-肌醇磷酸生成受到抑制。6. R 59,022和RG 80267单独或共同作用均未影响缓激肽刺激的[3H]-肌醇磷酸生成。7. 因此,虽然存在通过刺激蛋白激酶C抑制肌醇磷酸生成的机制,但这些研究未能表明该机制是由作用于与磷脂酶C相连受体的激动剂激活的。